FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Centrella, M.
Right arrow Articles by Canalis, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Centrella, M.
Right arrow Articles by Canalis, E.

The FASEB Journal, Vol 2, 3066-3073, Copyright © 1988 by The Federation of American Societies for Experimental Biology

REVIEWS

Skeletal tissue and transforming growth factor beta

M Centrella, TL McCarthy and E Canalis
Department of Medicine (Endocrine Division), Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105.

Normal skeletal growth results from a balance between the processes of bone matrix synthesis and resorption. These activities are regulated by both systemic and local factors. Bone turnover is dynamic, and skeletal growth must be maintained throughout life. Although many growth promoters are associated with bone matrix, it is enriched particularly with transforming growth factor beta (TGF-beta) activity. Experimental evidence indicates that TGF-beta regulates replication and differentiation of mesenchymal precursor cells, chondrocytes, osteoblasts, and osteoclasts. Recent studies further suggest that TGF- beta activity in skeletal tissue may be controlled at multiple levels by other local and systemic agents. Consequently, the intricate mechanisms by which TGF-beta regulates bone formation are likely to be fundamental to understanding the processes of skeletal growth during development, maintenance of bone mass in adult life, and healing subsequent to bone fracture.


This article has been cited by other articles:


Home page
 J. Cell Sci.Home page
H. Enomoto, T. Furuichi, A. Zanma, K. Yamana, C. Yoshida, S. Sumitani, H. Yamamoto, M. Enomoto-Iwamoto, M. Iwamoto, and T. Komori
Runx2 deficiency in chondrocytes causes adipogenic changes in vitro
J. Cell Sci., January 22, 2004; 117(3): 417 - 425.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
K. Janssens and W. Van Hul
Molecular genetics of too much bone
Hum. Mol. Genet., October 1, 2002; 11(20): 2385 - 2393.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
J. D. HECKMAN, W. EHLER, B. P. BROOKS, T. B. AUFDEMORTE, C. H. LOHMANN, T. MORGAN, and B. D. BOYAN
Bone Morphogenetic Protein But Not Transforming Growth Factor-{beta} Enchances Bone Formation in Canine Diaphyseal Nonunions Implanted with a Biodegradable Composite Polymer*{{dagger}}
J. Bone Joint Surg. Am., December 1, 1999; 81(12): 1717 - 29.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
Z. Schwartz, V. L. Sylvia, D. D. Dean, and B. D. Boyan
The Synergistic Effects of Vitamin D Metabolites and Transforming Growth Factor-{beta} on Costochondral Chondrocytes Are Mediated by Increases in Protein Kinase C Activity Involving Two Separate Pathways
Endocrinology, February 1, 1998; 139(2): 534 - 545.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by The Federation of American Societies for Experimental Biology.